Artificial intelligence and machine learning companies develop software, algorithms and computational platforms that analyse biological data, automate workflows and accelerate scientific discovery. These technologies are increasingly used across drug discovery, diagnostics, genomics and healthcare research.
This category includes companies working on:
Browse 243 UK AI and machine learning companies below.
Laboratory information systems and digital pathology software
Cirdan is a medical software company developing laboratory information systems and digital pathology solutions for clinical laboratories and pathology departments. Its integrated platform streamlines laboratory workflows, supports multi-site operations, and applies AI and data analytics to accelerate patient…
Laboratory information management and AI-enabled sample workflow software
Cenevo is a laboratory software company providing integrated systems for scientific sample management, research records and workflow automation. Its platforms combine electronic laboratory notebooks, laboratory information management, compound and biological sample tracking, inventory control and instrument…
FDA-approved AI blood test for diabetic kidney disease risk
Renalytix is an artificial intelligence-enabled in vitro diagnostics company focused on the clinical management of chronic kidney disease. Its blood-based test combines biomarker analysis with machine learning to generate a five-year kidney function decline risk score in adults with type 2 diabetes and CKD stages 1 to…
AI-driven liquid biopsy platform for early cancer biomarker discovery
BioMavericks is an early-stage biotechnology company developing an AI-driven liquid biopsy platform for the early detection of cancer. Its lead product targets the discovery and validation of blood-based biomarkers for early-stage pancreatic cancer diagnostics, integrating molecular cell biology, multi-omics data…
AI-driven skin microbiome platform for skincare and drug discovery
Biotix is a biotechnology company applying artificial intelligence and microbiome science to discover and develop novel approaches for skin health. Its AI platform analyses proprietary microbiome and clinical datasets to identify beneficial skin microbes and their metabolites, supporting both a commercial skincare…
AI-driven digital modelling platform for pharmaceutical process development
PolyModels Hub is a software company developing a digital platform that uses physics-based and AI-driven models to help pharmaceutical process scientists design, simulate and optimise manufacturing processes. The platform replaces traditional experiment-heavy development workflows with predictive digital modelling,…
AI platform for pharma drug discovery workflows
DaltonTx is a technology company building adaptive AI-enabled discovery platforms for the pharmaceutical industry. Its disease- and modality-agnostic platform integrates into pharma, biotech and CRO workflows, supporting both small molecule and biologics discovery through a self-learning system that improves with…
3D immune-microtumour platform for cancer treatment selection
Pear Bio is a biotechnology company that tests cancer treatment efficacy directly on patient-derived tumour samples using three-dimensional immune-microtumour cultures and computer vision analysis. By culturing tumour biopsies with matched patient immune cells and imaging drug effects over time, the platform generates…
AI-powered medical imaging software for stroke, oncology and lung disease
Brainomix is a UK software company specialising in AI-powered imaging biomarkers and Software as a Medical Device (SaMD) to support clinical decision-making in stroke, lung fibrosis, and cancer. Its platform provides clinicians with automated imaging analysis to guide treatment decisions in acute stroke care and is…
Non-endoscopic molecular diagnostics for early oesophageal cancer detection
Cyted Health is a gastrointestinal molecular diagnostics company developing minimally invasive testing for early detection and monitoring of oesophageal pre-cancer and cancer. Its platform combines a swallowable capsule sponge cell collection device with AI-driven biomarker molecular assays to detect Barrett's…
Multiplexed imaging platform for therapeutic mechanism of action discovery
Micrographia Bio is a biotechnology company developing a spatial proteomics platform for drug discovery. Its technology combines highly multiplexed microscopy with machine-intelligent computer vision to autonomously determine the mechanism of action of therapeutic candidates by visualising protein-protein interactions…
AI-driven precision fermentation for sustainable ingredients
Twig Bio is a bioengineering company using AI and laboratory automation to develop sustainable, bio-fermented alternatives to petrochemical and agriculturally derived ingredients. Its platform combines machine learning-guided pathway design with high-throughput robotic strain building and screening, enabling rapid…
AI-driven discovery of fungal natural product therapeutics
Novogaia is a biotechnology company using machine learning and analytical chemistry to discover drug-like molecules from fungi. Its Gaia-01 model predicts molecular structures from mass spectrometry data, enabling researchers to characterise natural compounds and identify chemical starting points for drug discovery.…
Raman spectroscopy blood test for early cancer detection
CanSense is a Welsh biotechnology company developing a non-invasive blood test for the early detection of bowel and other cancers. The platform combines Raman laser spectroscopy with artificial intelligence to identify cancer-associated metabolic signatures in blood, delivering results within 48 hours without…
Causal cellular data and AI models for drug discovery
CellCodex is a biotechnology company that generates causal data from human cells to train predictive models for drug discovery. It programmes stem cells into pure, aged, disease-relevant cell types, perturbs them at genome scale with CRISPR and compounds, and reads the outcome in single cells. The company applies the…
Personalised cancer treatment selection using in vivo drug screening
Vivan Therapeutics is a London-based biotech developing a personalised cancer therapeutics platform. The company's Personal Discovery Process sequences a patient's tumour genome, engineers those mutations into a fruit fly avatar model, and screens thousands of approved drug combinations at high throughput to identify…
AI-powered RNAi drug discovery company developing hepatic medicines
Tangram Therapeutics is a biotechnology company combining artificial intelligence and RNA interference to discover and develop novel medicines. Its proprietary chemistry platform silences disease-driving genes in hepatocytes, and its AI platform drives target identification and siRNA design. The pipeline includes…
AI-powered rapid pathogen ID and antibiotic susceptibility from blood
Vivid Dx is a University of Oxford spin-out developing a culture-free diagnostics platform for rapid pathogen identification and antimicrobial susceptibility testing directly from blood samples. The system combines Raman spectroscopy, microfluidics, and deep learning to deliver species-level pathogen identification in…
AI-powered digital pathology laboratory services for rapid cancer diagnosis
Inify Laboratories is a digital pathology company providing cancer diagnostic services through a fully digital, AI-supported laboratory workflow. The company processes tissue biopsy samples, generating whole slide images that are analysed by its proprietary AI software before review and reporting by specialist…
Targeted oncology combination therapies in biomarker-defined cancer populations
Mosaic Therapeutics is a Cambridge biotech developing targeted combination therapies for cancer. Its proprietary platform integrates genome-scale CRISPR screening, high-throughput combination drug testing across over 1,300 patient-derived tumour models, and advanced computational analysis to identify synergistic drug…